Liver transplants are more common than most people realize, and the numbers keep climbing. In 2023, the United States performed a record 10,659 liver transplants, while roughly 41,100 were performed worldwide. That U.S. total represents a 71% increase over the past decade, driven by expanding donor pools, improved surgical techniques, and a shifting landscape of liver disease.
Annual Volume in the U.S. and Worldwide
The U.S. leads the world in liver transplant volume, followed by India (about 3,640 transplants in 2023) and Spain (about 2,250). Of the 10,659 U.S. transplants in 2023, 95% went to adult recipients and 5% to children. To put this in perspective, liver transplantation is the second most common solid organ transplant after kidney, which sees roughly 27,000 per year in the U.S.
Despite record numbers, demand still outpaces supply. Thousands of people are added to the waiting list each year, and not everyone receives an organ in time. The gap between available organs and patients who need them has narrowed over the past decade but hasn’t closed.
Why People Need Liver Transplants
The reasons people end up needing a new liver have changed dramatically in the last 15 years. Hepatitis C used to be the leading cause, but highly effective antiviral medications developed in the 2010s sharply reduced the need for transplants related to that virus.
Today, alcohol-associated liver disease is the single largest reason for liver transplantation, accounting for 41.1% of recipients in 2023. That’s a striking shift: before 2011, alcohol-related cases made up only 12 to 19% of transplants. In raw numbers, alcohol-related transplants tripled from 805 in 2011 to 2,534 in 2023. The second most common indication is fatty liver disease (now called metabolic dysfunction-associated steatotic liver disease), responsible for about 20% of transplants. This condition is closely tied to obesity, diabetes, and metabolic syndrome, and its share continues to grow.
Liver cancer, most often hepatocellular carcinoma, accounts for 30 to 40% of liver transplants depending on the center. Many of these cancers develop in livers already damaged by chronic disease, so there’s significant overlap between cancer cases and the conditions listed above.
Pediatric Liver Transplants
Children make up a small but important share of transplant recipients. In a typical recent year, around 500 pediatric liver transplants are performed in the U.S. The most common reason is biliary atresia, a condition present at birth where the bile ducts are blocked or absent, accounting for about a third of pediatric cases. Metabolic disorders, other bile duct conditions, acute liver failure, and a childhood liver cancer called hepatoblastoma round out the most frequent diagnoses.
Long-Term Survival After Transplant
Liver transplant outcomes have improved steadily over the decades. Current data show five-year survival rates around 71% and ten-year survival around 59%, though these numbers vary depending on the underlying disease, the patient’s overall health at the time of surgery, and the transplant center’s experience. Patients transplanted for some conditions, like certain metabolic diseases, tend to have better long-term outcomes than those transplanted for advanced cancer.
The first year after transplant carries the highest risk, primarily from surgical complications, organ rejection, and infection. After that initial period, survival curves flatten out considerably. Most recipients return to normal daily activities within three to six months, though they take immune-suppressing medications for life to prevent their body from attacking the new organ.
Trends Driving the Numbers Up
Several forces explain why liver transplant volume has grown so sharply. The obesity epidemic has fueled a rise in fatty liver disease, which can progress silently over years before causing irreversible scarring. Alcohol consumption patterns have also shifted, with increasing rates of heavy drinking contributing to more cases of severe, transplant-requiring liver damage. Many transplant centers have also relaxed the traditional rule requiring six months of sobriety before listing a patient, recognizing that some people with acute alcohol-related liver failure benefit from earlier transplantation.
On the supply side, transplant programs have expanded the criteria for acceptable donor organs, using livers from older donors and donors with certain medical conditions that would have been ruled out in previous decades. Living donor transplantation, where a healthy person donates a portion of their liver that regenerates in both the donor and recipient, has also grown as a way to address the organ shortage. These changes together explain why the U.S. has been able to set new transplant records year after year.